Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Molecular Biology of the Cell
|
March 24, 2017
Direct measurement of the strength of microtubule attachment to yeast centrosomes
Kimberly K Fong, Krishna K Sarangapani, Erik C Yusko, et al.
JCI Insight
|
July 13, 2018
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
Alexander C Hopkins, Mark Yarchoan, Jennifer N Durham, et al.
Nature Nanotechnology
|
December 20, 2016
Real-time shape approximation and fingerprinting of single proteins using a nanopore
Erik C Yusko, Brandon R Bruhn, Olivia M Eggenberger, et al.
Journal for Immunotherapy of Cancer
|
October 25, 2018
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
Ahmad Tarhini, Yan Lin, Huang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2017
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade
Simon J Dovedi, Eleanor J Cheadle, Amy L Popple, et al.
Cancer Immunology, Immunotherapy : CII
|
January 29, 2019
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma
David Agdashian, Mei ElGindi, Changqing Xie, et al.
Cell Reports
|
October 24, 2019
T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis
Caren Ramien, Erik C Yusko, Jan Broder Engler, et al.
The Lancet. Oncology
|
April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
Cancer Discovery
|
July 23, 2017
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence
Alexandre Reuben, Rachel Gittelman, Jianjun Gao, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Molecular Biology of the Cell
|
March 24, 2017
Direct measurement of the strength of microtubule attachment to yeast centrosomes
Kimberly K Fong, Krishna K Sarangapani, Erik C Yusko, et al.
JCI Insight
|
July 13, 2018
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
Alexander C Hopkins, Mark Yarchoan, Jennifer N Durham, et al.
Nature Nanotechnology
|
December 20, 2016
Real-time shape approximation and fingerprinting of single proteins using a nanopore
Erik C Yusko, Brandon R Bruhn, Olivia M Eggenberger, et al.
Journal for Immunotherapy of Cancer
|
October 25, 2018
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
Ahmad Tarhini, Yan Lin, Huang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2017
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade
Simon J Dovedi, Eleanor J Cheadle, Amy L Popple, et al.
Cancer Immunology, Immunotherapy : CII
|
January 29, 2019
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma
David Agdashian, Mei ElGindi, Changqing Xie, et al.
Cell Reports
|
October 24, 2019
T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis
Caren Ramien, Erik C Yusko, Jan Broder Engler, et al.
The Lancet. Oncology
|
April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
Cancer Discovery
|
July 23, 2017
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence
Alexandre Reuben, Rachel Gittelman, Jianjun Gao, et al.
Page
of 2